{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:19:37Z","timestamp":1792095577067,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1007627725251","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T10:54:50Z","timestamp":1040554490000},"page":"1173-1184","source":"Crossref","is-referenced-by-count":119,"title":["Neuroinflammatory Signaling Upregulation in Alzheimer's Disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Walter J.","family":"Lukiw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"290405_CR1","first-page":"61","volume":"257","author":"H. Braak","year":"1997","unstructured":"Braak, H. and Braak, E. 1997. Staging of Alzheimer-related cortical destruction. Int. Psychogeriatr. 257:61.","journal-title":"Int. Psychogeriatr."},{"key":"290405_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.ne.17.030194.002421","volume":"17","author":"D. J. Selkoe","year":"1994","unstructured":"Selkoe, D. J. 1994. Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17:489-517.","journal-title":"Ann. Rev. Neurosci."},{"key":"290405_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1357-4310(98)01229-5","volume":"4","author":"W. J. Ray","year":"1998","unstructured":"Ray, W. J., Ashall, F., and Goate, A. M. 1998. Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease. Molec. Med. Today 4:151-157.","journal-title":"Molec. Med. Today"},{"key":"290405_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(99)00301-7","volume":"47","author":"P. H. St. George-Hyslop","year":"2000","unstructured":"St. George-Hyslop, P. H. 2000. Molecular genetics of Alzheimer's disease. Biol. Psychiatry 47:183-199.","journal-title":"Biol. Psychiatry"},{"key":"290405_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"P. L. McGeer","year":"1995","unstructured":"McGeer, P. L. and McGeer, E G. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218.","journal-title":"Brain Res. Rev."},{"key":"290405_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"P. L. McGeer","year":"1996","unstructured":"McGeer, P. L., Schulzer, M., and McGeer, E. G. 1996. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease; a review of 17 epidemiologic studies. Neurology 47:425-432.","journal-title":"Neurology"},{"key":"290405_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.1993.2474","volume":"197","author":"M. R. Emmerling","year":"1993","unstructured":"Emmerling, M. R., Moore, C. J., Doyle, P. D., Carroll, R. T., and Davis, R. E. 1993. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197:292-297.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"290405_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C","volume":"27","author":"D. Stephenson","year":"1999","unstructured":"Stephenson, D., Rash, K., Smalstig, B., Roberts, E., Johnstone, E., Sharp, J., Panetta, J., Little, S., Kramer, R., and Clemens, J. 1999. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 27:110-128.","journal-title":"Glia"},{"key":"290405_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1681.2000.03200.x","volume":"27","author":"G. Halliday","year":"2000","unstructured":"Halliday, G., Robinson, S. R., Shepherd, C., and Kril, J. 2000. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27:1-8.","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"290405_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<937::AID-JNR4>3.0.CO;2-E","volume":"50","author":"W. J. Lukiw","year":"1997","unstructured":"Lukiw, W. J. and Bazan, N. G. 1997. Cyclooxygenase-2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. PMID: 9452008; UI: 98112387. J. Neurosci. Res. 50:937-945.","journal-title":"J. Neurosci. Res."},{"key":"290405_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.0.CO;2-5","volume":"53","author":"W. J. Lukiw","year":"1998","unstructured":"Lukiw, W. J. and Bazan, N. G. 1998. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J. Neurosci. Res. 53:583-592.","journal-title":"J. Neurosci. Res."},{"key":"290405_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0306-4522(98)00218-8","volume":"87","author":"G. M. Pasinetti","year":"1998","unstructured":"Pasinetti, G. M. and Aisen, P. S. 1998. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324.","journal-title":"Neuroscience"},{"key":"290405_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0079-6123(08)63215-X","volume":"118","author":"N. G. Bazan","year":"1998","unstructured":"Bazan, N. G. 1998. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog. Brain Res. 118:281-291.","journal-title":"Prog. Brain Res."},{"key":"290405_CR14","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.1074\/jbc.270.47.28257","volume":"270","author":"E. M. Rockenstein","year":"1995","unstructured":"Rockenstein, E. M., McConlogue, L., Tan, H., et al. 1995. Levels and alternative splicing of amyloid beta protein precurser (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. JBC 270:28257-28267.","journal-title":"JBC"},{"key":"290405_CR15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","volume":"77","author":"M. P. Mattson","year":"1997","unstructured":"Mattson, M. P. 1997. Cellular actions of beta-amyloid precurser protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1081-1132.","journal-title":"Physiol. Rev."},{"key":"290405_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A. Alzheimer","year":"1995","unstructured":"Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., et al. 1995. An English translation of Alzheimer's 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d Clin. Anat. 8:429-431.","journal-title":"Clin. Anat."},{"key":"290405_CR17","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","volume":"89","author":"T. Hla","year":"1992","unstructured":"Hla, T. and Neilson, K. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. 89:7384-7388.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"290405_CR18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1432-1033.1994.tb18804.x","volume":"221","author":"T. Kosaka","year":"1994","unstructured":"Kosaka, T., Miyata, A., Ihara, H., et al. 1994. Characterization of the human gene (PTGS2) encoding prostaglandinendoperoxide 2 synthase. Eur. J. Biochem. 221:889-897.","journal-title":"Eur. J. Biochem."},{"key":"290405_CR19","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.95.7.3914","volume":"95","author":"W. J. Lukiw","year":"1998","unstructured":"Lukiw, W. J., Pelaez, R. P., Martinez J., and Bazan, N. G. 1998. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1betainduced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. Proc. Natl. Acad. Sci. USA 95:3914-3919.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR20","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1523\/JNEUROSCI.17-08-02746.1997","volume":"17","author":"S. Nogawa","year":"1997","unstructured":"Nogawa, S., Zhang, F., Ross, M. E., et al. 1997. COX-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:2746-2755.","journal-title":"J. Neurosci."},{"key":"290405_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bj3180325","volume":"318","author":"A. Ristmaki","year":"1996","unstructured":"Ristmaki, A., Narko, K., and Hla, T. 1996. Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318:325-331.","journal-title":"Biochem. J."},{"key":"290405_CR22","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1073\/pnas.91.12.5252","volume":"91","author":"N. G. Bazan","year":"1994","unstructured":"Bazan, N. G., Fletcher, B. S., Herschman, H. R., et al. 1994. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc. Natl. Acad. Sci. USA 91:5252-5256.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR23","doi-asserted-by":"crossref","first-page":"24794","DOI":"10.1074\/jbc.271.40.24794","volume":"271","author":"V. L. Marcheselli","year":"1996","unstructured":"Marcheselli, V. L. and Bazan, N. G. 1996. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J. Biol. Chem. 271:24794-24799.","journal-title":"J. Biol. Chem."},{"key":"290405_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/glia.440070113","volume":"7","author":"D. W. Dickson","year":"1993","unstructured":"Dickson, D. W., Lee, S. C., Mattiace, L. A., et al. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.","journal-title":"Glia"},{"key":"290405_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/brbi.1995.1032","volume":"9","author":"S. C. Lee","year":"1995","unstructured":"Lee, S. C., Dickson, D. W., and Brosnan, C. F. 1995. Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun. 9:345-354.","journal-title":"Brain Behav. Immun."},{"key":"290405_CR26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0092-8674(86)90346-6","volume":"46","author":"R. Sen","year":"1986","unstructured":"Sen, R. and Baltimore, D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.","journal-title":"Cell"},{"key":"290405_CR27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"P. A. Baeuerle","year":"1994","unstructured":"Baeuerle, P. A. and Henkel, T. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.","journal-title":"Annu. Rev. Immunol."},{"key":"290405_CR28","first-page":"3981","volume":"14","author":"C. Kaltschmidt","year":"1994","unstructured":"Kaltschmidt, C., Kaltschmidt, B., and Neumann, H. 1994. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14:3981-3992.","journal-title":"Mol. Cell. Biol."},{"key":"290405_CR29","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","volume":"94","author":"B. Kaltschmidt","year":"1997","unstructured":"Kaltschmidt, B., Uherek, M., Volk, B., et al. 1997. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:2642-2647.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1357-2725(98)00081-8","volume":"30","author":"E. Stylianou","year":"1998","unstructured":"Stylianou, E. and Saklatvala, J. 1998. Interleukin-1. Int. J. Biochem. Cell Biol. 30:1075-1079.","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"290405_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0925-4773(93)90031-R","volume":"43","author":"C. Kaltschmidt","year":"1993","unstructured":"Kaltschmidt, C., Kaltschmidt, B., and Baeuerle, P. A. 1993. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech. Dev. 43:135-147.","journal-title":"Mech. Dev."},{"key":"290405_CR32","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/00001756-199709080-00025","volume":"8","author":"T. Suzuki","year":"1997","unstructured":"Suzuki, T., Mitake, S., Okumura-Noji, K., et al. 1997. Presence of NF-kappaB-like and IkappaB-like immunoreactivities in postsynaptic densities. Neuroreport 8:2931-2935.","journal-title":"Neuroreport"},{"key":"290405_CR33","doi-asserted-by":"crossref","first-page":"15836","DOI":"10.1016\/S0021-9258(19)49611-7","volume":"267","author":"E. Stylianou","year":"1992","unstructured":"Stylianou, E., O'Neill, L. A., Rawlinson, L., et al., 1992. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 267:15836-15841.","journal-title":"J. Biol. Chem."},{"key":"290405_CR34","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/j.1460-2075.1995.tb07287.x","volume":"14","author":"E. B. Traenckner","year":"1995","unstructured":"Traenckner, E. B., Pahl, H. L., Henkel, T., et al. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:2876-2883.","journal-title":"EMBO J."},{"key":"290405_CR35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1101\/gad.6.5.775","volume":"6","author":"T. Fujita","year":"1992","unstructured":"Fujita, T., Nolan, G. P., Ghosh, S., et al. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6:775-787.","journal-title":"Genes Dev."},{"key":"290405_CR36","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1101\/gad.9.22.2723","volume":"15","author":"I. M. Verma","year":"1995","unstructured":"Verma, I. M., Stevenson, J. K., Schwarz, E. M., et al. 1995. Rel\/NF-kappa B\/I kappa B family: intimate tales of association and dissociation. Genes Dev. 15:2723-2735.","journal-title":"Genes Dev."},{"key":"290405_CR37","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1097\/00001756-199709080-00009","volume":"8","author":"F. Boissiere","year":"1997","unstructured":"Boissiere, F., Hunot, S., Faucheux, B., et al. 1997. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8:2849-2852.","journal-title":"Neuroreport"},{"key":"290405_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"P. A. Baeuerle","year":"1996","unstructured":"Baeuerle, P. A. and Baltimore, D. 1996. NF-\u03baB: Ten years after. Cell 87:13-20.","journal-title":"Cell"},{"key":"290405_CR39","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1074\/jbc.271.25.15002","volume":"271","author":"M. Grilli","year":"1996","unstructured":"Grilli, M., Goffi, F., Memo, M., et al. 1996. Interleukin-1beta and glutamate activate the NK-kappaB\/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271:15002-15007.","journal-title":"J. Biol. Chem."},{"key":"290405_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/bbrc.1997.7064","volume":"237","author":"R. Newton","year":"1997","unstructured":"Newton, R., Kuitert, L. M., Bergmann, M., et al. 1997. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun. 237:28-32.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"290405_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0024-3205(96)00590-5","volume":"60","author":"R. Newton","year":"1997","unstructured":"Newton, R., Kuitert, L. M., Slater, D. M., et al. 1997. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60:67-78.","journal-title":"Life Sci."},{"key":"290405_CR42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(97)01362-8","volume":"418","author":"R. Newton","year":"1997","unstructured":"Newton, R., Stevens, D. A., Hart, L. A., et al. 1997. Superinduction of COX-2 mRNA by cycloheximide and interleukin-1 beta involves increased transcription and correlates with increased NF-kappaB and JNK a c t i v a t i o n. FEBS Lett. 418:135-138.","journal-title":"FEBS Lett."},{"key":"290405_CR43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/JMN:11:1:67","volume":"11","author":"W. J. Lukiw","year":"1998","unstructured":"Lukiw, W. J., LeBlanc, H. J., Carver, L. A., McLachlan, D. R., and Bazan, N. G. 1998. Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease. J. Mol. Neurosci. 11:67-78.","journal-title":"J. Mol. Neurosci."},{"key":"290405_CR44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","volume":"274","author":"M. Grilli","year":"1996","unstructured":"Grilli, M., Pizzi, M., Memo, M., et al. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science 274:1383-1385.","journal-title":"Science"},{"key":"290405_CR45","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1523\/JNEUROSCI.17-16-06057.1997","volume":"17","author":"L. Guerrini","year":"1997","unstructured":"Guerrini, L., Molteni, A., Wirth, T., et al. 1997. Glutamatedependent activation of NF-kappaB during mouse cerebellum development. J. Neurosci. 17:6057-6063.","journal-title":"J. Neurosci."},{"key":"290405_CR46","doi-asserted-by":"crossref","first-page":"19612","DOI":"10.1074\/jbc.271.32.19612","volume":"271","author":"C. Brostjan","year":"1996","unstructured":"Brostjan, C., Anrather, J., Csizmadia, V., et al. 1996. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J. Biol. Chem. 271:19612-19616.","journal-title":"J. Biol. Chem."},{"key":"290405_CR47","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1074\/jbc.274.13.8630","volume":"274","author":"W. J. Lukiw","year":"1999","unstructured":"Lukiw, W. J., Martinez, J., Pelaez, R. P., and Bazan, N. G. 1999. The interleukin-1 type 2 receptor gene displays immediate early gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes. J. Biol. Chem. 274:8630-8638.","journal-title":"J. Biol. Chem."},{"key":"290405_CR48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","volume":"77","author":"C. Behl","year":"1994","unstructured":"Behl, C., Davis, J. B., Lesley, R., et al. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827.","journal-title":"Cell"},{"key":"290405_CR49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1996.tb39057.x","volume":"786","author":"K. Hensley","year":"1996","unstructured":"Hensley, K., Butterfield, D. A., Hall, N., et al. 1996. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Ann NY Acad. Sci. 786:120-134.","journal-title":"Ann NY Acad. Sci."},{"key":"290405_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","volume":"20","author":"L. A. O'Neill","year":"1997","unstructured":"O'Neill, L. A. and Kaltschmidt, C. 1997. NF-kappaB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:252-258.","journal-title":"Trends Neurosci."},{"key":"290405_CR51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1471-4159.1996.67020662.x","volume":"67","author":"Y. Rong","year":"1996","unstructured":"Rong, Y. and Baudry, M. 1996. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67:662-668.","journal-title":"J. Neurochem."},{"key":"290405_CR52","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1006\/bbrc.1995.2060","volume":"212","author":"A. Salminen","year":"1995","unstructured":"Salminen, A., Liu, P. K., and Hsu, C. Y. 1995. Alteration of transcription factor binding activities in the ischemic rat brain. Biochem. Biophys. Res. Commun. 212:939-944.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"290405_CR53","unstructured":"Colangelo, V., Lukiw, W. J., Gordon, W. C., et al. 1999. COX-2 as a mediator of cerebral ischemic tolerance. ASN Meeting abstract 95-S30B."},{"key":"290405_CR54","unstructured":"Lukiw, W. J. and Bazan, N. G. 2000. Presenilin-1 (PS1) and cyclooxygenase-2 (COX-2) genes exhibit coordinated transcription in experimental epileptogenesis. American Epilepsy Society Abstract. K.05."},{"key":"290405_CR55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0006-8993(96)01073-6","volume":"739","author":"K. Terai","year":"1996","unstructured":"Terai, K., Matsuo, A., McGeer, E. G., et al. 1996. Enhancement of immunoreactivity for NF-kappaB in human cerebral infarctions. Brain Res. 739:343-349.","journal-title":"Brain Res."},{"key":"290405_CR56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0098-2997(93)90004-W","volume":"14","author":"B. Kaltschmidt","year":"1993","unstructured":"Kaltschmidt, B., Baeuerle, P. A., and Kaltschmidt, C. 1993. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects Med. 14:171-190.","journal-title":"Mol. Aspects Med."},{"key":"290405_CR57","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S. Hunot","year":"1997","unstructured":"Hunot, S., Brugg, B., Ricard, D., et al. 1997. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. USA 94:7531-7536.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(97)00797-0","volume":"237","author":"Y. Kitamura","year":"1997","unstructured":"Kitamura, Y., Shimohama, S., Ota, T, et al. 1997. Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains. Neurosci. Lett. 237:17-20.","journal-title":"Neurosci. Lett."},{"key":"290405_CR59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/viro.1996.8299","volume":"227","author":"M. Liu","year":"1997","unstructured":"Liu, M., Kumar, K. U., Pater, M. M., et al. 1997. Dual NFl-requiring effect of human neurotropic JC virus composite pentanucleotide repeat elements on early and late viral gene expression. Virology 227:7-12.","journal-title":"Virology"},{"key":"290405_CR60","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0090-6980(97)00144-5","volume":"54","author":"D. J. Perkins","year":"1997","unstructured":"Perkins, D. J. and Kniss, D. A. 1997. Tumor necrosis factoralpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDS. Prostaglandins 54:727-743.","journal-title":"Prostaglandins"},{"key":"290405_CR61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0896-6273(90)90169-G","volume":"5","author":"R. L. Neve","year":"1990","unstructured":"Neve, R. L., Rogers, J., and Higgins, G. A. 1990. The Alzheimer amyloid precursor-related transcript lacking the beta\/A4 sequence is specifically increased in Alzheimer's disease brain. Neuron 5:329-338.","journal-title":"Neuron"},{"key":"290405_CR62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0169-328X(94)90039-6","volume":"22","author":"W. J. Lukiw","year":"1994","unstructured":"Lukiw, W. J., Rogaev, E. I., Wong, L., et al. 1994. Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex. Brain Res. Mol. Brain Res. 22:121-131.","journal-title":"Brain Res. Mol. Brain Res."},{"key":"290405_CR63","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0092-8674(00)80356-6","volume":"90","author":"J. Li","year":"1997","unstructured":"Li, J., Xu, M., Zhou, H., et al. 1997. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90:917-927.","journal-title":"Cell"},{"key":"290405_CR64","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1006\/bbrc.1997.7730","volume":"240","author":"K. Shirotani","year":"1997","unstructured":"Shirotani, K., Takahashi, K., Ozawa, K., et al. 1997. Determination of a cleavage site of presenilin 2 protein in stably transfected SH-SY5Y human neuroblastoma cell lines. Biochem. Biophys. Res. Commun. 240:728-731.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"290405_CR65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<99::AID-JNR10>3.0.CO;2-Y","volume":"53","author":"D. H. Chui","year":"1998","unstructured":"Chui, D. H., Shirotani, K., Tanahashi, H., et al. 1998. Both Nterminal and c-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease. J. Neurosci. Res. 53:99-106.","journal-title":"J. Neurosci. Res."},{"key":"290405_CR66","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1074\/jbc.273.16.9886","volume":"273","author":"A. G. Spencer","year":"1998","unstructured":"Spencer, A. G., Woods, J. W., Arakawa, T., et al. 1998. Subcellular localization of a prostaglandin endoperoxide H synthases-1 and-2 by immunoelectron microscopy. J. Biol. Chem. 273:9886-9893.","journal-title":"J. Biol. Chem."},{"key":"290405_CR67","unstructured":"Rogaev, E. I., Bazan, N. G., and Lukiw, W. J. 1998. Common regulatory elements in the promoters of genes linked to familial or sporadic Alzheimer's disease (AD). SFN 28th Annual Meeting; Los Angeles, CA."},{"key":"290405_CR68","unstructured":"Lukiw, W. J., Rogaev, E. I., and Bazan, N. G. 2000. Analysis of transcriptional regulatory mechanisms in nine genes associated with Alzheimer's disease (AD). J. Neurosci. Res. (Submitted)."},{"key":"290405_CR69","first-page":"3279","volume":"9","author":"S. Weggen","year":"1998","unstructured":"Weggen, S., Diehlmann, A., Buslei, R., et al. 1998. Prominent expression of presenilin-1 in senile plaques and reactive astrocytes in Alzheimer's disease brain. Neuroreport 9:3279-3283.","journal-title":"Neuroreport"},{"key":"290405_CR70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0169-328X(97)00337-9","volume":"54","author":"H. Tanimukai","year":"1998","unstructured":"Tanimukai, H., Imaizumi, K., Kudo, T., et al. 1998. Alzheimerassociated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Mol. Brain Res. 54:212-218.","journal-title":"Mol. Brain Res."},{"key":"290405_CR71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L. Holcomb","year":"1998","unstructured":"Holcomb, L., Gordon, M. N., McGowan, E., et al. 1998. Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:97-100.","journal-title":"Nat. Med."},{"key":"290405_CR72","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","volume":"86","author":"D. Goldgaber","year":"1989","unstructured":"Goldgaber, D., Harris, H. W., Hla, T., et al. 1989. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86:7606-7610.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02736923","volume":"12","author":"W. Tong","year":"1999","unstructured":"Tong, W., Shah, D., Xu, J., Diehl, J. A., Hans, A., Hannink, M., and Sun, G. Y. 1999. Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in Immortalized astrocytes (DITNC). J. Mol. Neurosci. 12:89-99.","journal-title":"J. Mol. Neurosci."},{"key":"290405_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1990.tb08813.x","volume":"55","author":"T. Shimizu","year":"1990","unstructured":"Shimizu, T. and Wolfe, L. S. 1990. Arachidonic acid cascade and signal transduction. J. Neurochem. 55:1-15.","journal-title":"J. Neurochem."},{"key":"290405_CR75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1615\/CritRevImmunol.v17.i3-4.10","volume":"17","author":"M. Murakami","year":"1997","unstructured":"Murakami, M., Nakatani, Y., Atsumi, G. Inoue, K., and Kudo, I. 1997. Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17:225-228.","journal-title":"Crit. Rev. Immunol."},{"key":"290405_CR76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jlb.65.3.330","volume":"65","author":"M. A. Gijon","year":"1999","unstructured":"Gijon, M. A. and Leslie, C. C. 1999. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol. 65:330-336.","journal-title":"J. Leukoc. Biol."},{"key":"290405_CR77","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1074\/jbc.274.8.5163","volume":"274","author":"T. Hirabayashi","year":"1999","unstructured":"Hirabayashi, T., Kume, K., Hirose, K., Yokomizo, T., Iino, M., Itoh, H., and Shimizu, T. 1999. Critical duration of intracellular Ca2+response required for continuous translocation and activation of cytosolic phospholipase A2. J. Biol. Chem. 274:5163-5169.","journal-title":"J. Biol. Chem."},{"key":"290405_CR78","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1074\/jbc.275.8.5785","volume":"275","author":"N. Suzuki","year":"2000","unstructured":"Suzuki, N., Ishizaki, J., Yokota, Y., Higashino, K., Ono, T., Ikeda, M., Fujii, N., Kawamoto, K., and Hanasaki, K. 2000. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J. Biol. Chem. 275:5785-5793.","journal-title":"J. Biol. Chem."},{"key":"290405_CR79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1054\/plef.1999.0038","volume":"61","author":"P. V. Peplow","year":"1999","unstructured":"Peplow, P. V. 1999. Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. Prostaglandins Leukot. Essent. Fatty Acids 61:65-82.","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"290405_CR80","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"D. A. Snowdon","year":"1997","unstructured":"Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. 1997. Brain infarction and the clinical expression of Alzheimer disease. JAMA 277:813-817.","journal-title":"JAMA"},{"key":"290405_CR81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.1997.03550020045023","volume":"278","author":"S. S. Mirra","year":"1997","unstructured":"Mirra, S. S. and Gearing, M. 1997. Brain infarction and the clinical expression of Alzheimer's disease. JAMA 278:113.","journal-title":"JAMA"},{"key":"290405_CR82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/WNL.51.1.159","volume":"51","author":"A. Heyman","year":"1998","unstructured":"Heyman, A., Fillenbaum, G. G., Welsh-Bohmer, K. A., et al. 1998. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 51:159-162.","journal-title":"Neurology"},{"key":"290405_CR83","unstructured":"Colangelo, V., Lukiw, W. J., Gordon, W. C., et al. 1999. COX-2 as a mediator of cerebral ischemic tolerance. ASN Meeting abstract 95-S30B."},{"key":"290405_CR84","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.94.17.9422","volume":"94","author":"G. Bing","year":"1997","unstructured":"Bing, G., Wilson, B., Hudson, P., Jin, L., Feng, Z., Zhang, W., Bing, R., and Hong, J. S. 1997. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Proc. Natl. Acad. Sci. USA 94:9422-9427.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290405_CR85","unstructured":"Lukiw, W. J., Tu, B., Marcheselli, V. L., and Bazan, N. G. 1999. Delayed hippocampal activation of the transcription factor NF-\u03baB in experimental epileptogenesis. AES 53rd Annual Meeting; Orlando."},{"key":"290405_CR86","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1076\/ceyr.17.9.947.5135","volume":"17","author":"P. H. Frederikse","year":"1998","unstructured":"Frederikse, P. H. and Zigler, J. S. Jr. 1998. Presenilin expression in the ocular lens. Current Eye Research 17:947-952.","journal-title":"Current Eye Research"},{"key":"290405_CR87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0197-4580(99)00065-2","volume":"20","author":"W. C. Benzing","year":"1999","unstructured":"Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D., Ashe, K. H., Younkin, S. G., and Brunden, K. R. 1999. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol. Aging 20:581-589.","journal-title":"Neurobiol. Aging"},{"key":"290405_CR88","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1993.tb03639.x","volume":"61","author":"P. W. Mantyh","year":"1993","unstructured":"Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., and Maggio, J. E. 1993. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61:1171-1174.","journal-title":"J. Neurochem."},{"key":"290405_CR89","first-page":"113","volume-title":"Mineral and Metal Neurotoxicology","author":"W. J. Lukiw","year":"1997","unstructured":"Lukiw, W. J. 1997. Aluminum in Alzheimer's disease. Pages 113-126 in Yasui, M., Strong, M., Ota, K., and Verity, M. A. (eds.), Mineral and Metal Neurotoxicology, CRC Press, Boca Raton Florida."},{"key":"290405_CR90","first-page":"397","volume":"223","author":"A. Campbell","year":"2000","unstructured":"Campbell, A., Kumar, A., La Rosa, F. G., Prasad, K. N., and Bondy, S. C. 2000. Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. Proc. Soc. Exp. Biol. Med. 223:397-402.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"290405_CR91","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/nbdi.1996.0005","volume":"3","author":"D. T. Stephenson","year":"1996","unstructured":"Stephenson, D. T., Lemere, C. A., Selkoe, D. J., and Clemens, J. A. 1996. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3:51-63.","journal-title":"Neurobiol. Dis."},{"key":"290405_CR92","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1021\/bi9911839","volume":"38","author":"M. E. King","year":"1999","unstructured":"King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. 1999. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 38:14851-14859.","journal-title":"Biochemistry"},{"key":"290405_CR93","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1471-4159.2000.0741017.x","volume":"74","author":"S. L. Yates","year":"2000","unstructured":"Yates, S. L., Burgess, L. H., Kocsis-Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., and Brunden, K. R. 2000. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74:1017-1025.","journal-title":"J. Neurochem."},{"key":"290405_CR94","doi-asserted-by":"crossref","first-page":"11976","DOI":"10.1016\/S0021-9258(19)50296-4","volume":"268","author":"M. Abdel-Ghany","year":"1993","unstructured":"Abdel-Ghany, M., el-Sebae, A. K., and Shalloway, D. 1993. Aluminum-induced nonenzymatic phospho-incorporation into human tau and other proteins. J. Biol. Chem. 268:11976-11981.","journal-title":"J. Biol. Chem."},{"key":"290405_CR95","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1016\/S0021-9258(17)32694-7","volume":"269","author":"A. I. Bush","year":"1994","unstructured":"Bush, A. I., Pettingell, W. H. Jr., Paradis, M. D., and Tanzi, R. E. 1994. Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269:12152-12158.","journal-title":"J. Biol. Chem."},{"key":"290405_CR96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2362.1999.00472.x","volume":"29","author":"R. D. Moir","year":"1999","unstructured":"Moir, R. D., Atwood, C. S., Huang, X., Tanzi, R. E., and Bush, A. I. 1999. Mounting evidence for the involvement of zinc and copper in Alzheimer's disease. Eur. J. Clin. Invest. 29:569-570.","journal-title":"Eur. J. Clin. Invest."},{"key":"290405_CR97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0162-0134(99)00125-7","volume":"76","author":"C. Exley","year":"1999","unstructured":"Exley, C. 1999. A molecular mechanism of aluminium-induced Alzheimer's disease? J. Inorg. Biochem. 76:133-140.","journal-title":"J. Inorg. Biochem."},{"key":"290405_CR98","doi-asserted-by":"crossref","first-page":"621S","DOI":"10.1093\/ajcn\/71.2.621s","volume":"71","author":"Y. Christen","year":"2000","unstructured":"Christen, Y. 2000. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:621S-629S.","journal-title":"Am. J. Clin. Nutr."},{"key":"290405_CR99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/nbdi.1997.0163","volume":"4","author":"M. P. Cuajungco","year":"1997","unstructured":"Cuajungco, M. P. and Lees, G. J. 1997. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol. Dis. 4:137-169.","journal-title":"Neurobiol. Dis."},{"key":"290405_CR100","first-page":"209","volume":"19","author":"J. Savory","year":"1998","unstructured":"Savory, J., Huang, Y., Wills, M. R., and Herman, M. M. 1998. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminuminduced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease. Neurotoxicology 19:209-214.","journal-title":"Neurotoxicology"},{"key":"290405_CR101","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(99)02096-X","volume":"852","author":"S. W. Suh","year":"2000","unstructured":"Suh, S. W., Jensen, K. B., Jensen, M. S., Silva, D. S., Kesslak, P. J., Danscher, G., and Frederickson, C. J. 2000. Histochemically reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852:274-278.","journal-title":"Brain Res."},{"key":"290405_CR102","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1021\/bi00435a043","volume":"28","author":"P. R. Walker","year":"1989","unstructured":"Walker, P. R., LeBlanc, J., and Sikorska, M. 1989. Effects of aluminum and other cations on the structure of brain and liver chromatin. Biochemistry 28:3911-3915.","journal-title":"Biochemistry"},{"key":"290405_CR103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jlb.67.1.127","volume":"67","author":"A. Klegeris","year":"2000","unstructured":"Klegeris, A. and McGeer, P. L. 2000. Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J. Leukoc. Biol. 67:127-133.","journal-title":"J. Leukoc. Biol."},{"key":"290405_CR104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0891-5849(95)02058-6","volume":"20","author":"I. Ceballos-Picot","year":"1996","unstructured":"Ceballos-Picot, I., Merad-Boudia, M., Nicole, A., Thevenin, M., Hellier, G., Legrain, S., and Berr, C. 1996. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radic. Biol. Med. 20:579-587.","journal-title":"Free Radic. Biol. Med."},{"key":"290405_CR105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.285.5425.175","volume":"285","author":"M. Barinaga","year":"1999","unstructured":"Barinaga, M. 1999. An immunization against Alzheimer's? Science 285:175-177.","journal-title":"Science"},{"key":"290405_CR106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0929-7855(96)01501-5","volume":"14","author":"R. M. Kramer","year":"1996","unstructured":"Kramer, R. M., Stephenson, D. T., Roberts, E. F., and Clemens, J. A. 1996. Cytosolic phospholipase A2 (cPLA2) and lipid mediator release in the brain. J. Lipid Mediat. Cell Signal 14:3-7.","journal-title":"J. Lipid Mediat. Cell Signal"},{"key":"290405_CR107","unstructured":"Lukiw, W. J., Rodriguez de Turco, E. B., and Bazan, N. G. 2000. Brain phospholipase A2 (PLA2) in cerebral injury, neural degeneration and Alzheimer's disease. Biochemica et Biophysica Acta (Submitted)."},{"key":"290405_CR108","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","volume":"20","author":"C. K. Combs","year":"2000","unstructured":"Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., and Landreth, G. E. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR gamma agonists. J. Neurosci. 20:558-567.","journal-title":"J. Neurosci."},{"key":"290405_CR109","first-page":"313","volume":"31","author":"E. T. Sutton","year":"1999","unstructured":"Sutton, E. T., Thomas, T., Bryant, M. W., Landon, C. S., Newton, C. A., and Rhodin, J. A. 1999. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. J. Submicrosc. Cytol. Pathol. 31:313-323.","journal-title":"J. Submicrosc. Cytol. Pathol."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007627725251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007627725251\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007627725251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:28:30Z","timestamp":1751866110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007627725251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":109,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["290405"],"URL":"https:\/\/doi.org\/10.1023\/a:1007627725251","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}